Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Shulan Pi"'
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
Externí odkaz:
https://doaj.org/article/fa45dbc19a3147538fec7c9b015c17c5
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Low-density lipoprotein receptor–related protein-1 (LRP1) is a large endocytic and signaling receptor belonging to the LDL receptor (LDLR) gene family and that is widely expressed in several tissues. LRP1 comprises a large extracellular domain (ECD
Externí odkaz:
https://doaj.org/article/c200095e23604bdb9080e36625f66185
Autor:
Yuanyuan Li, Yanan Li, Yiliang Miao, Hui He, Yu Hu, Jianyong Liu, Huijuan Jin, Jiefang Chen, Bo Hu, Hanqing Shi, Yiping Dang, Yuxiao Liu, Yuan-Peng Xia, Shulan Pi, Xiaoqing Guo, Ling Mao, Zhenyu Yue, Lian Zhou, Quan-Wei He, Cheng Yu
Publikováno v:
Autophagy
Vascular smooth muscle cells (VSMCs) are an important source of foam cells in atherosclerosis. The mechanism for VSMC-derived foam cell formation is, however, poorly understood. Here, we demonstrate that the P2RY12/P2Y12 receptor is important in regu
Publikováno v:
Frontiers in Cardiovascular Medicine
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Low-density lipoprotein receptor–related protein-1 (LRP1) is a large endocytic and signaling receptor belonging to the LDL receptor (LDLR) gene family and that is widely expressed in several tissues. LRP1 comprises a large extracellular domain (ECD
P2Y receptors (P2YRs), a δ group of rhodopsin-like G protein-coupled receptors (GPCRs), have many essential functions in physiology and pathology, such as platelet aggregation, immune responses, neuroprotective effects, inflammation, and cellular pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2de26497c6007f91e5571c263ed85e21
https://doi.org/10.22541/au.160684078.83449304/v1
https://doi.org/10.22541/au.160684078.83449304/v1
Autor:
Hui He, Hanqing Shi, Jiefang Chen, Yuan-Peng Xia, Yuxiao Liu, Bo Hu, Xiaoqing Guo, Yuanyuan Li, Cheng Yu, Shulan Pi, Ling Mao, Lian Zhou
Publikováno v:
Arteriosclerosis, thrombosis, and vascular biology. 40(6)
Objective: Recent studies suggest that the P2Y12 (P2Y purinoceptor 12) receptor of vascular smooth muscle cells in atherosclerotic plaques aggravates atherosclerosis, and P2Y12 receptor inhibitors such as CDL (clopidogrel) may effectively treat ather
Publikováno v:
Cellular and Molecular Life Sciences. 76:341-354
Atherosclerosis is a chronic and progressive disease of the arterial walls and a leading cause of non-cardioembolic ischemic stroke. P2Y12 is a well-recognized receptor that is expressed on platelets and is a target of thienopyridine-type antiplatele
Publikováno v:
Biochemical Pharmacology. 192:114689
P2Y receptors (P2YRs) are a δ group of rhodopsin-like G protein-coupled receptors (GPCRs) with many essential functions in physiology and pathology, such as platelet aggregation, immune responses, neuroprotective effects, inflammation, and cellular
Autor:
Quan-Wei He, Ling Mao, Man Li, Huijuan Jin, Shulan Pi, Yuan-Peng Xia, Suraj Baral, Yanan Li, Bo Hu, Xuan Niu, Mengdie Wang
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 37:515-524
Objective— P2Y 12 is a well-recognized receptor expressed on platelets and the target of thienopyridine-type antiplatelet drugs. However, recent evidence suggests that P2Y 12 expressed in vessel wall plays a role in atherogenesis, but the mechanism
Publikováno v:
Cellular and molecular life sciences : CMLS. 76(2)
Atherosclerosis is a chronic and progressive disease of the arterial walls and a leading cause of non-cardioembolic ischemic stroke. P2Y